Antoine Bouchard‐Fortier

ORCID: 0000-0001-9399-8372
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Intraperitoneal and Appendiceal Malignancies
  • Global Cancer Incidence and Screening
  • Appendicitis Diagnosis and Management
  • Ovarian cancer diagnosis and treatment
  • Sarcoma Diagnosis and Treatment
  • Breast Lesions and Carcinomas
  • Breast Implant and Reconstruction
  • Economic and Financial Impacts of Cancer
  • Estrogen and related hormone effects
  • Multiple and Secondary Primary Cancers
  • Colorectal Cancer Screening and Detection
  • Tumors and Oncological Cases
  • Gastric Cancer Management and Outcomes
  • Renal cell carcinoma treatment
  • Metastasis and carcinoma case studies
  • Occupational and environmental lung diseases
  • Cutaneous Melanoma Detection and Management
  • Soft tissue tumor case studies
  • Body Contouring and Surgery
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Advanced Breast Cancer Therapies
  • Genetic factors in colorectal cancer
  • HER2/EGFR in Cancer Research
  • Bariatric Surgery and Outcomes

University of Calgary
2016-2025

Foothills Medical Centre
2016-2023

Hôpital Maisonneuve-Rosemont
2016-2020

Université de Montréal
2016-2020

Memorial Sloan Kettering Cancer Center
2020

University of Alberta
2019

Centre hospitalier universitaire de Québec
2013

Université Laval
2013

Centre Hospitalier de l’Université de Montréal
2011

Recurrence is not explicitly documented in cancer registry data that are widely used for research. Patterns of events after initial treatment such as oncology visits, re-operation, and receipt subsequent chemotherapy or radiation may indicate recurrence. This study aimed to develop validate algorithms identifying breast recurrence using routinely collected administrative data. The cohort included all young (≤ 40 years) patients (2007–2010), receiving neoadjuvant (2012–2014) Alberta, Canada....

10.1186/s12885-019-5432-8 article EN cc-by BMC Cancer 2019-03-08

Purpose: Anti-hormonal therapy (tamoxifen) is recommended for estrogen receptor (er)–positive breast cancer (bca); however, its effect on low-receptor cancers unclear. We retrospectively evaluated the of adjuvant tamoxifen in patients with weakly er-positive bca. Methods: identified 2221 bca who had been er-tested by ligand-based assay (lba) during 1976–1995 and treated followed until 2008. Cox proportional hazards models adjusted age, body mass index, tumour size, nodal status, surgery,...

10.3747/co.24.3238 article EN cc-by Current Oncology 2017-04-01

Background The majority of women in Nigeria present with advanced‐stage breast cancer. To address the role geospatial access, we constructed a geographic information‐system–based model to evaluate relationship between modeled travel time, stage at presentation, and overall survival among patients cancer Nigeria. Methods Consecutive were identified from single‐institution, prospective database (May 2009‐January 2019). Patients geographically located, time hospital was generated using...

10.1002/cncr.33394 article EN Cancer 2020-12-28

Background. Transcatheter arterial lipiodol chemoembolization (TACE) can be used in cirrhotic patients with hepatocellular carcinoma to avoid tumor progression before transplantation. Objective. To evaluate the efficacy and safety of TACE as a bridge liver Methods. was performed 30 carcinoma. Milan criteria were select for transplant. Patients had good or moderately impaired function, no arterioportal fistulae, portal perfusion. Results. 48 patients. Before transplantation, 4 dropped off...

10.4061/2011/974514 article EN cc-by International Journal of Hepatology 2011-01-01

To evaluate the utility of multidisciplinary case conferences (MCCs) on physician decision making in benign and malignant breast disease management. Patients with interesting or challenging diagnostic management issues were discussed at biweekly MCCs. Prior to discussion, a clinical summary intended plan prior MCC was presented. For each case, images/histopathology centrally reviewed after which group discussion achieved consensus documented prospectively. Initial plans compared post-MCC...

10.7759/cureus.895 article EN Cureus 2016-11-24

Introduction: Retroperitoneal sarcoma (rps) encompasses a heterogeneous group of malignancies with high recurrence rate after resection. Neoadjuvant radiotherapy (nrt) is often used in the hope sterilizing margins and decreasing local excision. We set out to compare recurrence-free survival (lrfs) overall (os) patients treated or without nrt before Methods: Patients diagnosed rps from February 1990 October 2014 were identified Alberta Cancer Registry. complete gross resection no distant...

10.3747/co.26.5185 article EN cc-by Current Oncology 2019-12-01

Background and Objectives Using a 2 mm margin criteria, we evaluated the effect of intra‐operative assessment on status re‐excisions following breast‐conserving surgery (BCS) for ductal carcinoma in situ (DCIS). Methods We identified patients undergoing BCS DCIS from prospective, population‐based database. Multivariable logistic regression was used to determine specimen mammography, ultrasound macroscopic by pathologist margins re‐excision rates. Results In 588 patients, 52% (95% confidence...

10.1002/jso.25248 article EN Journal of Surgical Oncology 2018-10-07

Current guidelines recommending wide local excision (≥ 1 cm margin) for all breast phyllodes tumours regardless of classification are based on retrospective data. Benign the not aggressive. They often indistinguishable from fibroadenomas core biopsy and diagnosed only after excisions without attention to margins. Once diagnosis is made, decision operate obtain further margins versus wait-and-watch dilemma surgeons face a regular basis.

10.1503/cjs.017617 article EN Canadian Journal of Surgery 2018-11-23

Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a major treatment of colorectal peritoneal carcinomatosis (CPC). The aim was to determine the disease-free survival (DFS) and overall (OS) patients undergoing CRS-HIPEC for CPC factors associated long-term (LTS).

10.3390/curroncol31070269 article EN cc-by Current Oncology 2024-06-25

Peritoneal recurrences after cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) for appendiceal colorectal cancers are frequent. This study aimed to evaluate the safety, technical feasibility perioperative long-term outcomes of repeat CRS/HIPEC in patients with recurrent peritoneal carcinomatosis origin.Data were collected from treated 2000 2016 or cancer at 2 specialist centres. Data on demographics, procedure details, morbidity survival recorded. Analyses compared...

10.1503/cjs.002519 article FR Canadian Journal of Surgery 2020-01-01

Abstract Introduction Peritoneal mesothelioma (PM) is a rare malignancy originating from the peritoneal lining. Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) standard‐of‐care for patients with isolated PM. Due to paucity of prospective data there are several different HIPEC protocols. The aims this study describe CRS protocols PM patient outcomes across Canada. Methods A multicenter retrospective was performed on diagnosed treated in four major disease centers...

10.1002/jso.27301 article EN Journal of Surgical Oncology 2023-05-30
Coming Soon ...